March 2, 2020 / 8:02 AM / a month ago

BRIEF-Nanogroup Gets Nanosanguis Comparative Analysis Results Enabling Co To Start Registration in 2020

March 2 (Reuters) - Nanogroup SA:

* RECEIVES COMPARATIVE ANALYSIS RESULTS FOR NANOSANGUIS PERFUSION SOLUTION FROM AMERICAN HEART OF POLAND

* SAYS ACCORDING TO MANAGEMENT RESULTS WILL ENABLE CO TO BEGIN REGISTRATION PROCESS FOR PRODUCT WITH FDA AND EMA Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below